A novel potential therapy for diabetic nephropathy and vascular complications: protein kinase C beta inhibition (Q35211693)

7 August 2017

1 reference

title

A novel potential therapy for diabetic nephropathy and vascular complications: protein kinase C beta inhibition (English)

1 reference

7 August 2017

1 reference

1

Katherine R Tuttle

1 reference

7 August 2017

Pamela W Anderson

2

1 reference

7 August 2017

publication date

1 September 2003

1 reference

American Journal of Kidney Diseases

7 August 2017

published in

1 reference

7 August 2017

volume

42

1 reference

7 August 2017

issue

3

1 reference

7 August 2017

page(s)

456-465

1 reference

Effective Antihypertensive Treatment Postpones Renal Insufficiency in Diabetic Nephropathy

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

The relationship between glucose control and the development and progression of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

The effect of metabolic control on rate of decline in renal function in insulin-dependent diabetes mellitus with overt diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Prevalence of Arterial Hypertension in Diabetic Patients Before and After the JNC-V

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Angiotensin II stimulates human fetal mesangial cell proliferation and fibronectin biosynthesis by binding to AT1 receptors.

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Effect of insulin therapy on renal hemodynamic response to amino acids and renal hypertrophy in non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Additive antiproteinuric effect of ACE inhibition and a low-protein diet in human renal disease

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Nutritional therapy for progressive renal failure.

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Diabetic nephropathy in type II diabetes

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Role of nutrition in prevention of the progression of renal disease

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Cholesterol: a renal risk factor in diabetic nephropathy?

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Low-density lipoprotein apheresis retards the progression of hyperlipidemic overt diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Reduction of Albumin Excretion Rate in Normotensive Microalbuminuric Type 2 Diabetic Patients During Long-Term Simvastatin Treatment

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Can reduction in hypertriglyceridaemia slow progression of microalbuminuria in patients with non-insulin-dependent diabetes mellitus?

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Effect of lipid reduction on the progression of renal disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Characterization of glucose-induced in situ protein kinase C activity in cultured vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Glucose-induced protein kinase C activity regulates arachidonic acid release and eicosanoid production by cultured glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Activation of protein kinase C in glomerular cells in diabetes. Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Translocation of protein kinase C alpha and zeta in rat glomerular mesangial cells cultured under high glucose conditions

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

(S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Prevention of diabetic nephropathy by diet control in the db/db mouse

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR)

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Protein kinase C beta inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Aminoguanidine and ramipril prevent diabetes-induced increases in protein kinase C activity in glomeruli, retina and mesenteric artery

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Role of protein kinase C in angiotensin II-induced constriction of renal microvessels

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Urinary albumin and insulin as predictors of coronary artery disease: An angiographic study

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Diabetes and cardiovascular disease. The Framingham study

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Nitric oxide inhibition of transforming growth factor-beta and collagen synthesis in mesangial cells

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Glycated albumin stimulates TGF-beta 1 production and protein kinase C activity in glomerular endothelial cells

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo : a specific vascular action of insulin.

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00741-8

7 January 2021

10.1016/S0272-6386(03)00741-8

Identifiers

DOI

1 reference

7 August 2017

1 reference